FTC starts probe into Teva about some products' patents, …
WEBJul 1, 2024 — The U.S. Federal Trade Commission has opened an investigation into Teva Pharmaceutical over the company's refusal to take down about two dozen patents for its asthma and COPD inhalers, the...
FTC launches investigation into Teva's inhaler patents: report
WEBJul 2, 2024 — Now, as the situation escalates, the FTC has launched an investigation into the Israeli-American drug giant over Teva’s refusal to remove roughly two dozen patents for its asthma and...
FTC Files Amicus Brief in Asthma Inhaler Patent Dispute
WEBMar 22, 2024 — The Federal Trade Commission filed an amicus brief explaining that pharmaceutical maker Teva has improperly listed patents in the Food and Drug Administration’s (FDA) Orange Book and urged the court to order those listings removed.
FTC opens investigation into Teva over 'improper' patents - STAT
WEBJul 1, 2024 — T he Federal Trade Commission is formally investigating Teva Pharmaceuticals after the company refused to remove approximately two dozen patents for asthma and COPD inhalers from a key...
FTC starts probe into Teva about some products' patents ... - Yahoo
WEBJul 1, 2024 — (Reuters) -The U.S. Federal Trade Commission has opened an investigation into Teva Pharmaceutical over the company's refusal to take down about two dozen patents for its asthma and COPD inhalers,...
FTC opens investigation into Teva, escalating patent fight with ... - MSN
WEBThe Federal Trade Commission has opened an investigation into Teva Pharmaceuticals, citing the company’s refusal to take down about two dozen patents for its asthma and COPD inhalers, according...
FTC investigates Teva over contested product patents - Yahoo Finance
WEBJul 2, 2024 — Months after sending warning letters to pharma manufacturers challenging patents targeting drugs for diabetes, weight loss, and asthma, the Federal Trade Commission (FTC) has opened an...
FTC launches probe of Teva over ‘improper’ patents; report
WEBAug 14, 2024 — Shares in Teva Pharmaceutical have dipped sharply after reports that the Federal Trade Commission (FTC) has opened an investigation into the company focusing on improperly listed patents in the...
FTC Investigating Teva Over Contested Patents On Inhalers
WEBJul 2, 2024 — The Federal Trade Commission has opened an investigation into Teva Pharmaceuticals, citing the company’s refusal to take down about two dozen patents for its asthma and COPD inhalers, according to confidential agency documents reviewed by The Washington Post.
FTC Investigates Teva Over Refusal to Remove Improperly ... - BioSpace
WEBJul 2, 2024 — The Federal Trade Commission has opened an investigation into Teva Pharmaceuticals after the company allegedly ignored directives to withdraw or amend contentious patent listings on the FDA’s Orange Book.